Published in Melanoma Res on December 01, 2016
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. Lancet Oncol (2015) 3.57
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest (2014) 3.06
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Lancet Oncol (2015) 2.80
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys (2013) 2.28
Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. Cancer Immunol Res (2014) 2.00
The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol (2004) 1.94
Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys (2000) 1.68
Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses. Sci Transl Med (2012) 1.61
Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy. Ann Oncol (2015) 1.54
Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma. Cancer Treat Rev (2014) 1.39
Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database Syst Rev (2013) 1.09
Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Melanoma Res (2013) 1.08
The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys (2011) 1.04
Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes. Int J Radiat Oncol Biol Phys (2014) 1.03
The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer (2009) 1.02
A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiother Oncol (2006) 0.96
Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma. Lancet Oncol (2009) 0.94
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine (2015) 0.92
Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases. Neuro Oncol (2015) 0.92
Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev (2004) 0.91
Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys (2005) 0.90
Radiotherapy for cutaneous malignant melanoma: rationale and indications. Oncology (Williston Park) (2004) 0.88
Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. Onco Targets Ther (2011) 0.88
Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg (1986) 0.86
Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity. ANZ J Surg (2002) 0.85
Adjuvant radiotherapy for cutaneous melanoma. Cancer (2008) 0.80
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med (2011) 5.15
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl (2005) 2.43
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05
The importance of the conformality, heterogeneity, and gradient indices in evaluating Gamma Knife radiosurgery treatment plans for intracranial meningiomas. Int J Radiat Oncol Biol Phys (2011) 2.03
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry (2003) 1.90
A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg (2010) 1.83
Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US. Breast Cancer Res Treat (2012) 1.65
Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007) 1.63
Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach. Ann Surg Oncol (2015) 1.52
Changing management and outcome of hepatocellular carcinoma: evaluation of 501 patients treated at a single comprehensive center. J Surg Oncol (2008) 1.52
Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol (2009) 1.51
The 21-gene recurrence score and locoregional recurrence in breast cancer patients. Ann Surg Oncol (2014) 1.40
A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg (2009) 1.39
Risk modeling: applying evidence-based risk assessment in oncology nursing practice. Oncol Nurs Forum (2005) 1.39
Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody). J Immunother (2009) 1.36
Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer. Cancer Gene Ther (2002) 1.36
Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Cancer Res (2006) 1.35
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer (2010) 1.28
Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207). FASEB J (2004) 1.24
Patent foramen ovale and cryptogenic stroke. N Engl J Med (2013) 1.17
Regional recurrence after negative sentinel lymph node biopsy for melanoma. Ann Surg (2008) 1.12
Epidural analgesia in hepatic resection. J Am Coll Surg (2008) 1.04
The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys (2011) 1.04
Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol (2011) 1.03
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis. Ann Surg Oncol (2009) 1.03
The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia (2008) 1.03
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer. J Manag Care Pharm (2009) 1.01
Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer. Cancer (2014) 1.01
Scrotal cancer survival is influenced by histology: a SEER study. World J Urol (2012) 0.99
Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases. Am J Clin Oncol (2017) 0.94
Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma. Melanoma Res (2010) 0.94
Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. J Thorac Oncol (2015) 0.93
Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base. Ann Surg Oncol (2013) 0.92
Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms. Ann Surg Oncol (2010) 0.92
Videoscopic inguinal lymphadenectomy for metastatic melanoma. Cancer Control (2013) 0.92
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer. Cancer Med (2014) 0.91
Therapy for unresectable recurrent and in-transit extremity melanoma. Cancer Control (2008) 0.91
1 or 2 cm margins of excision for T2 melanomas: do they impact recurrence or survival? Ann Surg Oncol (2012) 0.91
Replication-competent herpes virus NV1020 as direct treatment of pleural cancer in a rat model. J Thorac Cardiovasc Surg (2002) 0.91
Breast reconstruction and post-mastectomy radiation practice. Radiat Oncol (2013) 0.90
Surface dose investigation of the flattening filter-free photon beams. Int J Radiat Oncol Biol Phys (2012) 0.90
Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications. J Urol (2012) 0.89
State-level cancer quality assessment and research: building and sustaining the data infrastructure. Cancer J (2011) 0.88
Functional, oncologic, and technical outcomes after endoscopic groin dissection for penile carcinoma. Can J Urol (2012) 0.88
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion. J Transl Med (2012) 0.87
Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone. J Neurooncol (2014) 0.87
Rising incidence of mucosal melanoma of the head and neck in the United States. J Skin Cancer (2012) 0.87
Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma. Am J Clin Oncol (2014) 0.86
Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. Int J Radiat Oncol Biol Phys (2013) 0.86
Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma. J Immunother (2015) 0.86
Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma. Am J Clin Oncol (2015) 0.86
Pediatric melanoma: analysis of an international registry. Cancer (2013) 0.86
Melanoma growth stimulatory activity in primary malignant melanoma: prognostic significance. Mod Pathol (2002) 0.85
The emerging role of radiotherapy for desmoplastic melanoma and implications for future research. Melanoma Res (2015) 0.84
Comparison of image-guided radiotherapy technologies for prostate cancer. Am J Clin Oncol (2014) 0.83
The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma. J Neurooncol (2003) 0.83
Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. Med Phys (2002) 0.83
Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma. Cancer (2013) 0.83
Plaque brachytherapy for uveal melanoma: a vision prognostication model. Int J Radiat Oncol Biol Phys (2012) 0.82
BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis. Melanoma Res (2016) 0.82
Gastrointestinal stromal tumors: a single institution experience of 176 surgical patients. Am Surg (2013) 0.82
Neoadjuvant induction chemotherapy followed by chemoradiation: a phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies. Surg Oncol Clin N Am (2004) 0.81
Analysis of regional recurrence after negative sentinel lymph node biopsy for head and neck melanoma. Head Neck (2012) 0.80
Renewed interest in the role of consolidative radiotherapy in advanced stage diffuse large B-cell lymphoma. Leuk Lymphoma (2013) 0.80
Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Am Surg (2007) 0.80
The non-Gaussian nature of prostate motion based on real-time intrafraction tracking. Int J Radiat Oncol Biol Phys (2013) 0.79
Local recurrence patterns in breast cancer patients treated with oncoplastic reduction mammaplasty and radiotherapy. Ann Surg Oncol (2013) 0.79
Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms. Arch Surg (2011) 0.79
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings. Neuropsychopharmacology (2013) 0.78
Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization. J Vasc Interv Radiol (2012) 0.78
Bilateral endoscopic inguinofemoral lymphadenectomy using simultaneous carbon dioxide insufflation: an initial report of a novel approach. Can J Urol (2012) 0.78
Current treatment of locoregional recurrence of melanoma. Curr Oncol Rep (2013) 0.78
The General Surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist? J Am Coll Surg (2013) 0.77
Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study. Am J Clin Oncol (2017) 0.77
Ipilimumab for advanced melanoma: let's not throw caution to the winds. Oncology (Williston Park) (2010) 0.77
Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma (2014) 0.77
Pediatric melanomas and the atypical spitzoid melanocytic neoplasms. Am J Surg (2011) 0.77
A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy. Ann Surg (2016) 0.76
Comparative effectiveness in melanoma. Cancer Treat Res (2015) 0.76
Complete response to high-dose IL-2 and enhanced IFNγ+Th17 : TREG ratio in a melanoma patient. Melanoma Res (2016) 0.76
A model and nomogram to predict tumor site origin for squamous cell cancer confined to cervical lymph nodes. Cancer (2014) 0.75
CD45/CD8 Myeloid Histioid Antigen and Plasma Cell Antibody Immune Response in a Case of Malignant Melanoma. N Am J Med Sci (2012) 0.75
Counting alleles in single lesions of prostate tumors from ethnically diverse patients. Prostate (2008) 0.75
Exogenous IL-2 Induces FoxP3+ Th17 Cells In Vivo in Melanoma Patients. J Immunother (2016) 0.75
Management of regional lymph node basins in melanoma. Ochsner J (2010) 0.75
Improving quality of surgical care and outcomes: factors impacting surgical site infection after colorectal resection. Am Surg (2014) 0.75